Home > Publications database > Dickkopf-3 Contributes to the Regulation of Anti-Tumor Immune Responses by Mesenchymal Stem Cells. > print |
001 | 127036 | ||
005 | 20240228140902.0 | ||
024 | 7 | _ | |a 10.3389/fimmu.2015.00645 |2 doi |
024 | 7 | _ | |a pmid:26734010 |2 pmid |
024 | 7 | _ | |a pmc:PMC4689786 |2 pmc |
024 | 7 | _ | |a altmetric:4919320 |2 altmetric |
037 | _ | _ | |a DKFZ-2017-03062 |
041 | _ | _ | |a eng |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Lu, Kun-Hui |0 P:(DE-HGF)0 |b 0 |e First author |
245 | _ | _ | |a Dickkopf-3 Contributes to the Regulation of Anti-Tumor Immune Responses by Mesenchymal Stem Cells. |
260 | _ | _ | |a Lausanne |c 2015 |b Frontiers Media |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1521625369_923 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
520 | _ | _ | |a Mesenchymal stem cells (MSCs) are known to limit immune responses in vivo by multiple soluble factors. Dickkopf-3 (DKK3), a secreted glycoprotein, has recently been identified as a novel immune modulator. Since DKK3 has been reported to be produced by MSCs, we investigated whether DKK3 contributes to the immune suppression of anti-tumor responses by MSCs. Whereas wild-type MSCs inhibited immune responses against two different transplantation tumors, DKK3-deficient MSCs did not affect the rejection process. Increased CD8(+) T cell and reduced M2-type macrophages infiltration was observed in tumors inoculated together with DKK3-deficient MSCs. Thus, DKK3 could alter the composition of the tumor stroma, thereby supporting the MSCs-mediated suppression of immune responses against these tumor transplants. |
536 | _ | _ | |a 314 - Tumor immunology (POF3-314) |0 G:(DE-HGF)POF3-314 |c POF3-314 |f POF III |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
700 | 1 | _ | |a Tounsi, Amel |0 P:(DE-HGF)0 |b 1 |
700 | 1 | _ | |a Shridhar, Naveen |b 2 |
700 | 1 | _ | |a Küblbeck, Günter |0 P:(DE-He78)b8759faaf3e907bcd8b6a34983994a3c |b 3 |u dkfz |
700 | 1 | _ | |a Klevenz, Alexandra |0 P:(DE-He78)de65818249a2e18aa4309f229917f4a4 |b 4 |u dkfz |
700 | 1 | _ | |a Prokosch, Sandra |0 P:(DE-He78)3c6157a315192b4a95e0138399b89da9 |b 5 |u dkfz |
700 | 1 | _ | |a Bald, Tobias |b 6 |
700 | 1 | _ | |a Tüting, Thomas |b 7 |
700 | 1 | _ | |a Arnold, Bernd |0 P:(DE-He78)554abc2af2666cc3421cc0d7f6e7b6de |b 8 |e Last author |u dkfz |
773 | _ | _ | |a 10.3389/fimmu.2015.00645 |g Vol. 6 |0 PERI:(DE-600)2606827-8 |p 645 |t Frontiers in immunology |v 6 |y 2015 |x 1664-3224 |
909 | C | O | |o oai:inrepo02.dkfz.de:127036 |p VDB |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 0 |6 P:(DE-HGF)0 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 1 |6 P:(DE-HGF)0 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 3 |6 P:(DE-He78)b8759faaf3e907bcd8b6a34983994a3c |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 4 |6 P:(DE-He78)de65818249a2e18aa4309f229917f4a4 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 5 |6 P:(DE-He78)3c6157a315192b4a95e0138399b89da9 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 8 |6 P:(DE-He78)554abc2af2666cc3421cc0d7f6e7b6de |
913 | 1 | _ | |a DE-HGF |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-314 |2 G:(DE-HGF)POF3-300 |v Tumor immunology |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |b Gesundheit |
914 | 1 | _ | |y 2015 |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b FRONT IMMUNOL : 2015 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |
915 | _ | _ | |a Creative Commons Attribution CC BY (No Version) |0 LIC:(DE-HGF)CCBYNV |2 V:(DE-HGF) |b DOAJ |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Thomson Reuters Master Journal List |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b FRONT IMMUNOL : 2015 |
920 | 1 | _ | |0 I:(DE-He78)D050-20160331 |k D050 |l Molekulare Immunologie |x 0 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)D050-20160331 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|